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A well-documented and accepted hypothesis of the origins
of diseases that occur with a high frequency in adulthood
is the causal relationship between an adverse intrauterine
environment during fetal life and development of diseases
including hypertension, diabetes, obesity, insulin resistance,
and metabolic syndrome [1, 2]. Epidemiological studies pro-
vided the impetus for experimental studies to identify cell and
molecular mechanisms that may underpin this relationship.
The precise mechanisms, however, remain only partially
described. It is anticipated that on-going studies will provide
data that more rigorously test this hypothesis and provide
insights into gestational age-dependent programming effects
and the consequences of alterations in intrauterine life on risk
profiles for adult diseases. To date, few studies have addressed
whether the preconception period is also involved in this
phenomenon [3]. Thus, it is clear that on-going investigative
effort in this field for a better understanding of the cellular
and molecular mechanisms underlying fetal programming
of adult diseases is required. This special issue includes
contributions over a wide area of expertise but particularly
studies concerning the vascular physiology/pathophysiology
of diseases of pregnancy that could result in programming of
the fetus leading to adult diseases.
The articles included in the present issue include both
clinical and basic science studies. The alterations caused by
exposure to elevated D-glucose environment are discussed
in chapters by J. B. Moreli et al. and D. C. Damasceno et al.
These articles reported that hyperglycaemia causes damage
to the maternal genetic material without a clear consensus
regarding the impact of this adverse environmental condition
on fetal cells. Since DNA repair mechanisms may be impor-
tant to prevent the deleterious effects of hyperglycaemia in
both the maternal and fetal DNA, it may be preventive of
the development of diseases in adulthood. Studies in animal
models support the targeting of the development of new
therapeutics thatminimise or prevent diabetes-inducedDNA
damage due to increased oxidative stress.
It is now clearer that maternal obesity is also a con-
dition that impacts on fetal growth and development [4].
The prevalence of obesity, especially in women of child-
bearing age, and a supraphysiological increase in gestational
weight gain during pregnancy is associated with adulthood
diseases. This is clearly summarized in the chapter by S. A.
Segovia et al. In addition, these authors highlight the fact
that the predisposition of offspring to obesity and metabolic
and cardiovascular disorders in later life occurs via poorly
described mechanisms including programming of metabolic
disorders. In this review, the authors discussed the possibility
that maternal obesity-related inflammation may program
insulin sensitivity of tissues in offspring. Interestingly, in the
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retrospective cohort study of 3290 children (age ∼11.5 years)
from Chile (South America), F. Mardones et al. identify an
association between prenatal growth and nutritional status,
metabolic syndrome, and insulin resistance. The authors
concluded that intrauterine growth is a factor influencing
the manifestation of pathologies such as metabolic syndrome
and insulin resistance. This study complements the review
by F. Westermeier et al. regarding the same concept; that
is, maternal obesity and neonatal insulin resistance associate
with long-term development of obesity, diabetes mellitus,
and increased global cardiovascular risk in the offspring.
The mechanisms at a cellular level, however, are not under-
stood.The authors summarize evidence showing that insulin
resistance in the offspring of pregnancies with maternal
obesity and/or supraphysiological gestational weight gain
(many of these patients ending with obesity) may result
from intrauterine activation of endoplasmic reticulum stress
response in human pregnancies.
Several articles report the potential effect of insulin as
a key factor to sustain human endothelial function via its
capacity to stimulate synthesis of nitric oxide and uptake
and metabolism of amino acids and other substrates [5].
Moreover, the biological actions of insulin appear to be
dependent on the activation of adenosine receptors expressed
in the endothelial cells from the human placenta [5, 6].
Indeed, adenosine may be a determinant in pregnancy
diseases associated with altered umbilical blood flow, such
as preeclampsia [7, 8]. Adenosine also increases human
umbilical vein endothelial cell (HUVEC) proliferation and
migration in preeclampsia, as reported by J. Acurio et al. The
proposed mechanisms include increased protein abundance
of A
2A adenosine receptors (A2AAR), but impaired nitric
oxide, and vascular endothelial growth factor signalling path-
way following activation of these receptors. The involvement
of other types of adenosine receptors, however, cannot be
ruled out in these studies, as stated by the authors in their dis-
cussion. Indeed, A
2AAR and A2BAR in endothelial cells from
fetoplacental circulation are proteins that could be involved
in similar mechanisms such as modulation of membrane
transporters of adenosine in HUVECs [9] and in human
microvascular endothelial cells [10]. Indeed, involvement of
A
1
AR in endothelial function has been recently regarded as
a potential receptor required for beneficial actions of insulin
in restoring functional alterations of HUVEC in gestational
diabetes (E. Guzma´n-Gutie´rrez, L. Sobrevia, unpublished).
Other types of membrane receptors are also involved in
placental dysfunction in preeclampsia. For example, in the
review by F. A. Zu´n˜iga et al., high levels of lectin-like oxidized
low-density lipoprotein receptor-1 are observed in the human
placenta from pregnancies complicated by preeclampsia.
How the activation of this type of receptors associates with
higher production of reactive oxygen species leading to
decreased intracellular NO bioavailability is described. It is
in fact a mechanism that could associate with other patho-
logical conditions, such as hypertension, hyperlipidaemia,
and diabetes. Preeclampsia is a disease described as “deep
placentation disorders” in the review by J. A. Carvajal. Since
docosahexaenoic acid supplementation during pregnancy
appears to prevent deep placentation disorders, the author
proposes that docosahexaenoic acid supplementation early
in pregnancy may help to reduce the incidence of deep pla-
centation disorders. Thus, this compound could be a strategy
for primary prevention of preeclampsia. More studies are
required to confirm or refute this proposal.
D. I. Chiarello et al. report the effects of hypoxia on
placental function, in particular, lipid peroxidation state of
syncytiotrophoblast plasma membranes. The authors con-
clude that increased membrane calcium content interacts
with phospholipids leading to exposure of hydrocarbon
chains of fatty acids to free radicals, where magnesium
might play a protective role. These findings could be key for
the understanding of the abnormal function of the human
placenta in states of hypoxia such as preeclampsia. In another
set of articles in this issue the effect of hypoxia on pregnancy is
reviewed by L.Wang et al. andA.-C. Peyter et al. Interestingly,
studying rats exposed to hypoxia, L. Wang et al. described
maternal hypoxia increased collagen (I and III) expression
in the left ventricle of adult offspring. This phenomenon,
however, is seen only with exposure during a critical window
(days 10th to 14th of gestation) of cardiovascular development
that results in pathological cardiac remodelling in the adult
rat offspring. Another study regarding hypoxia by A.-C.
Peyter et al. reported that inhaled nitric oxide administered
simultaneously to perinatal hypoxia in mice has beneficial
effects on the adult pulmonary circulation. Since inhaled
nitric oxide is the therapy of choice in neonates with
pulmonary hypertension, this article shows an interesting
set of results documenting that relaxation of adult mouse
pulmonary arteries to acetylcholine is restored following
inhaled nitric oxide.
This series of articles and reviews identifies putative
mechanisms that may impact on intrauterine life and pre-
dispose the newborn to adulthood diseases such as obesity,
diabetes, preeclampsia, and metabolic syndrome. Further
insights in the abnormal function of fetal cells, including
endothelium, placenta cells, and circulating blood cells,
is required to understand and to correlate these specific
mechanisms with adult diseases.
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